BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17148703)

  • 1. Prevention of venous thromboembolism in medically ill patients: a clinical update.
    Turpie AG; Leizorovicz A
    Postgrad Med J; 2006 Dec; 82(974):806-9. PubMed ID: 17148703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism in the medically ill patient: a call to action.
    Bergmann JF; Kher A
    Int J Clin Pract; 2005 May; 59(5):555-61. PubMed ID: 15857352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada.
    Kahn SR; Panju A; Geerts W; Pineo GF; Desjardins L; Turpie AG; Glezer S; Thabane L; Sebaldt RJ;
    Thromb Res; 2007; 119(2):145-55. PubMed ID: 16516275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolic prophylaxis in hospitalized medical patients.
    Stark JE; Kilzer WJ
    Ann Pharmacother; 2004 Jan; 38(1):36-40. PubMed ID: 14742790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A need for a simplified approach to venous thromboembolism prophylaxis in acute medical inpatients.
    Howard DP
    Int J Clin Pract; 2007 Feb; 61(2):336-40. PubMed ID: 16889637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolic risk and its prevention in hospitalized medical patients.
    Haas SK
    Semin Thromb Hemost; 2002 Dec; 28(6):577-84. PubMed ID: 12536351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis against venous thromboembolism in acutely ill medical patients: an observational study.
    Peterman CM; Kolansky DM; Spinler SA
    Pharmacotherapy; 2006 Aug; 26(8):1086-90. PubMed ID: 16863485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolic risk and prevention in acute medical illness.
    Hampton KK
    Int J Clin Pract; 2003 Jun; 57(5):424-7. PubMed ID: 12846349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study.
    Alikhan R; Cohen AT; Combe S; Samama MM; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Olsson CG; Turpie AG;
    Arch Intern Med; 2004 May; 164(9):963-8. PubMed ID: 15136304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism prophylaxis in medically ill patients and the development of strategies to improve prophylaxis rates.
    Stinnett JM; Pendleton R; Skordos L; Wheeler M; Rodgers GM
    Am J Hematol; 2005 Mar; 78(3):167-72. PubMed ID: 15726600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism: application and effectiveness of the American College of Chest Physicians 2001 guidelines for prophylaxis.
    Steier KJ; Singh G; Ullah A; Maneja J; Ha RS; Khan F
    J Am Osteopath Assoc; 2006 Jul; 106(7):388-95. PubMed ID: 16912336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism prevention in acutely ill nonsurgical patients.
    Brophy DF; Dougherty JA; Garrelts JC; Parish RC; Rivey MP; Stumpf JL; Taylor CT; Mathis AS
    Ann Pharmacother; 2005; 39(7-8):1318-24. PubMed ID: 15941823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation of enoxaparin as prophylaxis against venous thromboembolism in seriously ill medical patients: a US perspective.
    de Lissovoy G; Subedi P
    Am J Manag Care; 2002 Dec; 8(12):1082-8. PubMed ID: 12500884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Leizorovicz A; Cohen AT; Turpie AG; Olsson CG; Vaitkus PT; Goldhaber SZ;
    Circulation; 2004 Aug; 110(7):874-9. PubMed ID: 15289368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective review of the use of thromboprophylaxis in patients who subsequently developed a venous thromboembolism after discharge from hospital.
    Wiseman DN; Harrison J
    N Z Med J; 2010 Feb; 123(1309):37-49. PubMed ID: 20186241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparins in the prevention of venous thromboembolism in nonsurgical patients.
    Haas S
    Semin Thromb Hemost; 1999; 25 Suppl 3():101-5. PubMed ID: 10549724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of venous thromboembolic risk in acutely ill medical patients immobilized at home: the AT-HOME Study.
    Haas SK; Hach-Wunderle V; Mader FH; Ruster K; Paar WD
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):7-13. PubMed ID: 17164492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH; Muntz J
    Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of venous thromboembolism in internal medicine and neurology].
    Malý J; Dulícek P; Penka M; Malý R; Gumulec J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():63-7. PubMed ID: 16637452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.